89Zr-olaratumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-olaratumab, covering 2024-12-19 to 2024-12-19. Get the full timeline:
Most recent: Clinical Trial Update: 89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma [Phase 1]